TGFBR1 and nonpapillary renal cell carcinoma: Experimental in vitro and in vivo studies have indicated that TGBR3 have antitumoral effects in CCRCC cells independent of TGF-β1 and canonical TGFBR1/TGFBR2/SMAD signaling [11].